Lung Deposition of TRIMBOW® pMDI in Healthy Volunteers, Asthmatic and COPD Patients

PHASE1

Phase

TERMINATED

Status

Enrollment

INDUSTRY

Sponsor class

Stopped In light of the cessation of non-essential clinical activities at CPU due to the COVID-19 pandemic, the sponsor has determined to terminate the study early.

Conditions

Chronic Obstructive Pulmonary Disease
Asthma

Interventions

DRUG: Beclometasone dipropionate Formoterol Fumarate Glycopyrronium Bromide

Sponsor

Chiesi Farmaceutici S.p.A.